Zobrazeno 1 - 10
of 480
pro vyhledávání: '"S, Kiraz"'
Autor:
M Kiracı, E Bilgin, E Duran, B Farisoğulları, EC Bölek, GK Yardımcı, Z Ozsoy, G Ayan, GS Uzun, TH Akbaba, B Balci-Peynircioglu, O Karadag, A Akdogan, SA Bilgen, S Kiraz, AI Ertenli, U Kalyoncu, L Kılıç
Publikováno v:
Scandinavian Journal of Rheumatology. :1-9
To compare the demographic, clinical, and radiological features of patients with axial spondyloarthritis (axSpA) accompanying familial Mediterranean fever (FMF) to patients with each condition alone.Hacettepe University Hospital database was screened
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G. Ayan, G. Hatemi, G. Can, M. Bektaş, A. Ozdede, N. Akdogan, B. Yalici-Armagan, E. Oksum Solak, S. Yazici, E. Ozsoy Adisen, N. Atakan, E. Bulbul Baskan, M. Borlu, B. Engin, V. Hamuryudan, M. Inanc, S. Kiraz, F. Onen, S. Ugurlu, S. Yayli, U. Kalyoncu
Publikováno v:
Annals of the Rheumatic Diseases. 81:1597-1598
BackgroundPsoriatic arthritis (PsA) is a heterogenous disease with different disease manifestations. Several tools have been developed for screening of PsA in patients with psoriasis with variable performances. An optimal screening tool for PsA is st
Autor:
B. Yağiz, N. Lermi, B. N. Coşkun, E. Dalkiliç, S. Kiraz, A. İ. Ertenli, E. Bilgin, R. Yilmaz, A. Ateş, A. Tufan, R. Mercan, H. Cinakli, S. Akar, T. Kaşifoğlu, S. M. Türk, E. Gönüllü, A. Erden, C. Bes, H. Emmungil, U. Kalyoncu, Y. Pehlivan
Publikováno v:
Annals of the Rheumatic Diseases. 81:1513-1514
BackgroundBiologic agents have altered our ability to treat chronic inflammatory diseases effectively. Although paradoxical reactions (PRs) were initially described with TNF-α inhibitors, they have been reported with newly developed biologic agents
Publikováno v:
Czech Journal of Animal Science, Vol 50, Iss 8, Pp 362-368 (2005)
A study was conducted to determine the relationship between abdominal fat and the intake of methionine deficient diet in broilers. In this study, 66 male broilers at the age of 35 days were used. They were divided into two groups (control, n = 13, an
Externí odkaz:
https://doaj.org/article/6f7cfaeda2d14940ab52a5e5110c2c1d
Autor:
E. Durak Ediboglu, U. Kalyoncu, D. Solmaz, T. Kaşifoğlu, E. Tekgoz, C. Bes, A. Erden, B. Yağiz, N. A. Kanitez, A. İ. Ertenli, B. N. Coşkun, R. Mercan, S. Kiraz, V. Yazisiz, O. Küçükşahin, A. Ateş, R. Yilmaz, Y. Pehlivan, H. Emmungil, N. S. Yasar Bilge, G. Kimyon, E. D. Ersözlü, E. Dalkiliç, S. S. Koca, S. Akar
Publikováno v:
Annals of the Rheumatic Diseases. 81:812.2-813
BackgroundAxial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease affecting sacroiliac joints, spine and peripheral joints. In addition to spinal and peripheral manifestations, root joints (hip or sholder) involvement may also dev
Autor:
M. Kiraci, E. Bilgin, E. Duran, B. Farisogullari, E. C. Bolek, G. K. Yardimci, Z. Özsoy, G. Ayan, G. Sandal Uzun, T. H. Akbaba, B. B. Peynircioglu, O. Karadag, A. Akdoğan, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu, L. Kiliç
Publikováno v:
Annals of the Rheumatic Diseases. 81:797.1-797
BackgroundThe incidence of co-occurrence of FMF and axial spondyloarthritis (axSpA) in adults is reported to be 0.5-7.5%. M694V mutation is the most frequent variant in patients with FMF+AxSpA (1).ObjectivesTo evaluate the association of demographic
Autor:
G. Sandal Uzun, A. Taghiyeva, İ. Y. Çakir, K. Moral, E. Bilgin, G. K. Yardimci, B. Farisogullari, E. C. Bolek, E. Duran, Z. Özsoy, G. Ayan, M. Ekici, E. Unaldi, L. Kiliç, A. Akdoğan, O. Karadag, Ş. A. Bilgen, S. Kiraz, A. İ. Ertenli, U. Kalyoncu
Publikováno v:
Annals of the Rheumatic Diseases. 81:1303.1-1303
BackgroundRheumatic disesases may involve multiple systems and chronic kidney disease (CKD) can be seen during the course of diseases. Accompanying CKD affects the the choice of treatments in patients with rheumatic disease. There is limited data on